Product Information
PENTASA 250 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $2.9024 per EA under NDC 54092018981. Its NADAC has been published 644 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the mesalamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092018981
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
New Drug (NDA)
FDA Application
NDA020049On Market Since
5/10/1993
Pharmacological Classes
Price Statistics
The NADAC for PENTASA 250 MG CAPSULE has been published 644 times since Nov 28, 2013, and over the history we have for it it has risen 76.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9024 per EA |
|---|---|
| All-time high | $2.9261 (Aug 14, 2019) |
| All-time low | $1.6478 (Nov 28, 2013) |
| 52-week high | $2.9126 |
| 52-week low | $2.9024 |
| Median price | $2.9056 |
| Average price | $2.6668 |
| Largest weekly change | +9.0% (Apr 8, 2015) |
| Weeks tracked | 644 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the mesalamine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PENTASA 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PENTASA 250 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $2.9024 per EA (NDC 54092018981), effective Jun 24, 2026.
How has the price of PENTASA 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PENTASA 250 MG CAPSULE has risen 76.1%. It has been tracked across 644 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PENTASA 250 MG CAPSULE?
Since Nov 28, 2013, the NADAC for PENTASA 250 MG CAPSULE has ranged from a low of $1.6478 (Nov 28, 2013) to a high of $2.9261 (Aug 14, 2019), with a median of $2.9056 per EA.
Are there cheaper alternatives to PENTASA 250 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PENTASA 250 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures PENTASA 250 MG CAPSULE?
PENTASA 250 MG CAPSULE (NDC 54092018981) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.